Myriad Genetics | MYGN - Current Liabilities



Myriad Genetics reported $151.1M in Current Liabilities for its fiscal quarter ending in March of 2025.


Current Liabilities Change Date
Agilent USD 1.89B 120M Jul/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Bruker USD 1.35B 2.5M Jun/2025
Danaher USD 6.79B 147M Jun/2025
Exact Sciences USD 521.93M 19.47M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Illumina USD 1.46B 21M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Mettler Toledo International USD 1.11B 42.8M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Quidel USD 1.14B 94.9M Jun/2025
Repligen USD 152M 25.21M Mar/2025
Revvity USD 671.81M 23.63M Jun/2025
Standard Biotools USD 98.02M 32.13M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Veracyte USD 76.43M 1.31M Jun/2025
Waters USD 1.02B 55.16M Jun/2025